226 related articles for article (PubMed ID: 18687705)
21. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways.
Montezano AC; Callera GE; Yogi A; He Y; Tostes RC; He G; Schiffrin EL; Touyz RM
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1511-8. PubMed ID: 18467645
[TBL] [Abstract][Full Text] [Related]
22. Additive beneficial effects of the combination of a calcium channel blocker and an angiotensin blocker on a hypertensive rat-heart failure model.
Kim-Mitsuyama S; Izumi Y; Izumiya Y; Yoshida K; Yoshiyama M; Iwao H
Hypertens Res; 2004 Oct; 27(10):771-9. PubMed ID: 15785013
[TBL] [Abstract][Full Text] [Related]
23. Unique atheroprotective property of azelnidipine, a dihydropyridine-based calcium antagonist.
Nakamura K; Yamagishi S; Inoue H
Med Hypotheses; 2005; 65(1):155-7. PubMed ID: 15893134
[TBL] [Abstract][Full Text] [Related]
24. Effects of azelnidipine on the autonomic functions and its influence on arterial stiffness and endothelial functions.
Yamada J; Tomiyama H; Matsumoto C; Yoshida M; Shiina K; Yamashina A
J Cardiol; 2008 Apr; 51(2):114-20. PubMed ID: 18522784
[TBL] [Abstract][Full Text] [Related]
25. Azelnidipine attenuates cardiovascular and sympathetic responses to air-jet stress in genetically hypertensive rats.
Nakamoto M; Ohya Y; Sakima A; Yamazato M; Takishita S
Hypertens Res; 2007 Apr; 30(4):359-66. PubMed ID: 17541215
[TBL] [Abstract][Full Text] [Related]
26. Beneficial effects of combination therapy with olmesartan and azelnidipine in murine polycystic kidneys.
Tanifuji C; Suzuki Y; Geot WM; Horikoshi S; Takahashi H; Tomino Y
Kidney Blood Press Res; 2009; 32(4):239-49. PubMed ID: 19752573
[TBL] [Abstract][Full Text] [Related]
27. VEGF-induced retinal angiogenic signaling is critically dependent on Ca²⁺ signaling by Ca²⁺/calmodulin-dependent protein kinase II.
Banumathi E; O'Connor A; Gurunathan S; Simpson DA; McGeown JG; Curtis TM
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3103-11. PubMed ID: 21310919
[TBL] [Abstract][Full Text] [Related]
28. Effects of a new calcium channel blocker, azelnidipine, on systemic hemodynamics and renal sympathetic nerve activity in spontaneously hypertensive rats.
Shokoji T; Fujisawa Y; Kiyomoto H; Rahman M; Sun GP; Fan YY; Kimura S; Kohno M; Abe Y; Nishiyama A
Hypertens Res; 2005 Dec; 28(12):1017-23. PubMed ID: 16671342
[TBL] [Abstract][Full Text] [Related]
29. Ca2+ and inositol 1,4,5-trisphosphate-mediated signaling across the myoendothelial junction.
Isakson BE; Ramos SI; Duling BR
Circ Res; 2007 Feb; 100(2):246-54. PubMed ID: 17218602
[TBL] [Abstract][Full Text] [Related]
30. Role of integrin-linked kinase in vascular smooth muscle cells: regulation by statins and angiotensin II.
Friedrich EB; Clever YP; Wassmann S; Werner N; Böhm M; Nickenig G
Biochem Biophys Res Commun; 2006 Oct; 349(3):883-9. PubMed ID: 16962068
[TBL] [Abstract][Full Text] [Related]
31. Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
Li L; Gao PJ; Xi R; Wu CF; Zhu DL; Yan J; Lu GP
Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1471-6. PubMed ID: 18759864
[TBL] [Abstract][Full Text] [Related]
32. Pressure promotes DNA synthesis in rat cultured vascular smooth muscle cells.
Hishikawa K; Nakaki T; Marumo T; Hayashi M; Suzuki H; Kato R; Saruta T
J Clin Invest; 1994 May; 93(5):1975-80. PubMed ID: 8182128
[TBL] [Abstract][Full Text] [Related]
33. Regression of glomerular and tubulointerstitial injuries by dietary salt reduction with combination therapy of angiotensin II receptor blocker and calcium channel blocker in Dahl salt-sensitive rats.
Rafiq K; Nishiyama A; Konishi Y; Morikawa T; Kitabayashi C; Kohno M; Masaki T; Mori H; Kobori H; Imanishi M
PLoS One; 2014; 9(9):e107853. PubMed ID: 25233358
[TBL] [Abstract][Full Text] [Related]
34. Platelet derived growth factor-evoked Ca2+ wave and matrix gene expression through phospholipase C in human pulmonary fibroblast.
Mukherjee S; Duan F; Kolb MR; Janssen LJ
Int J Biochem Cell Biol; 2013 Jul; 45(7):1516-24. PubMed ID: 23618877
[TBL] [Abstract][Full Text] [Related]
35. Anti-atherogenic effects of the combination therapy with olmesartan and azelnidipine in diabetic apolipoprotein E-deficient mice.
Noda K; Hosoya M; Nakajima S; Ohashi J; Fukumoto Y; Shimokawa H
Tohoku J Exp Med; 2012 Dec; 228(4):305-15. PubMed ID: 23124103
[TBL] [Abstract][Full Text] [Related]
36. Co-treatment with azelinidipine and olmesartan inhibits advanced glycation end products (AGEs) elicited down-regulation of adiponectin mRNA levels in cultured adipocytes partly via its anti-oxidative property.
Maeda S; Matsui T; Takeuchi M; Yamagishi S
Int J Cardiol; 2011 Jan; 146(2):264-6. PubMed ID: 21095028
[No Abstract] [Full Text] [Related]
37. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
38. Azelnidipine decreases sympathetic nerve activity via antioxidant effect in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats.
Konno S; Hirooka Y; Araki S; Koga Y; Kishi T; Sunagawa K
J Cardiovasc Pharmacol; 2008 Dec; 52(6):555-60. PubMed ID: 19057394
[TBL] [Abstract][Full Text] [Related]
39. Intracellular actions of angiotensin II in vascular smooth muscle cells.
Haller H; Lindschau C; Quass P; Luft FC
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S75-83. PubMed ID: 9892144
[TBL] [Abstract][Full Text] [Related]
40. Slow calcium signals after tetanic electrical stimulation in skeletal myotubes.
Eltit JM; Hidalgo J; Liberona JL; Jaimovich E
Biophys J; 2004 May; 86(5):3042-51. PubMed ID: 15111418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
